Compare Adaptive Biotechnologies Corp (ADPT) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Tilray Brands Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Tilray Brands Inc trades at $4.78 (market cap $649.42M). The key difference: Adaptive Biotechnologies Corp is far larger — about 6.2× Tilray Brands Inc's market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| ADPT | TLRY | |
|---|---|---|
Market Cap | $4.04B | $649.42M |
Sector | Health | Health |
52-Week High | $25.45 | $21.00 |
52-Week Low | $12.30 | $3.88 |
Enterprise Value | $4.10B | $816.55M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
